Polymorphism in F pocket affects peptide selection and stability of type 1 diabetes‐associated HLA‐B39 allotypes
European Journal of Immunology · 2024
DOI: 10.1002/eji.202350683 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von A W Peshala Amarajeewa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Peptides, HLA-B Antigens. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Gebze Technical University BAP.
Themen: Diabetes mellitus
Abstract (Originalsprache)
HLA‐B*39:06, HLA‐B*39:01, and HLA‐B*38:01 are closely related HLA allotypes differentially associated with type 1 diabetes (T1D) risk and progression. B*39:06 is highly predisposing, while B*39:01 and B*38:01 are weakly predisposing and protective allotypes, respectively. Here, we aimed to decipher molecular mechanisms underlying the differential association of these allotypes with T1D pathogenesis. We addressed peptide binding and conformational stability of HLA‐B allotypes using computational and experimental approaches. Computationally, we found that B*39:06 and B*39:01 allotypes had more rigid peptide‐binding grooves and were more promiscuous in binding peptides than B*38:01. Peptidomes of B*39:06 and B*39:01 contained fewer strong binders and were of lower affinity than that of B*38:01. Experimentally, we demonstrated that B*39:06 and B*39:01 had a higher capacity to bind peptides and exit to the cell surface but lower surface levels and were degraded faster than B*38:01. In summary, we propose that promiscuous B*39:06 and B*39:01 may bind suboptimal peptides and transport them the cell surface, where such unstable complexes may contribute to the pathogenesis of T1D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Core Research Laboratory, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Bioengineering, Faculty of Engineering, Marmara University, Istanbul, Türkiye.
- Department of Endocrinology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Tumor and Immunology, Precision Medical Institute, Western China Science and Technology Innovation Port, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Bioengineering, Faculty of Engineering, Gebze Technical University, Gebze, Türkiye.
ORCID-Profile: A W Peshala Amarajeewa, Xu Ren, Pemra Ozbek, Malgorzata A Garstka, Onur Serçinoğlu
Förderung
- National Natural Science Foundation of China
- Gebze Technical University BAP
Zitieren
APA
Amarajeewa, A. W. P., Özcan, A., Mukhtiar, A., Ren, X., Wang, Q., Ozbek, P., Garstka, M. A., & Serçinoğlu, O. (2024). Polymorphism in F pocket affects peptide selection and stability of type 1 diabetes‐associated HLA‐B39 allotypes. European Journal of Immunology. https://doi.org/10.1002/eji.202350683
Vancouver
Amarajeewa AWP, Özcan A, Mukhtiar A, Ren X, Wang Q, Ozbek P, et al. Polymorphism in F pocket affects peptide selection and stability of type 1 diabetes‐associated HLA‐B39 allotypes. European Journal of Immunology. 2024. doi:10.1002/eji.202350683
BibTeX
@article{Amarajeewa2024,
author = {Amarajeewa, A W Peshala and Özcan, Aslihan and Mukhtiar, Alveena and Ren, Xu and Wang, Qianyu and Ozbek, Pemra and Garstka, Malgorzata A and Serçinoğlu, Onur},
title = {Polymorphism in F pocket affects peptide selection and stability of type 1 diabetes‐associated HLA‐B39 allotypes},
journal = {European Journal of Immunology},
year = {2024},
doi = {10.1002/eji.202350683}
}
EUVIMED